Literature DB >> 32024385

Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy.

Astrid Monfort1,2, Rishika Banydeen2,3, Fabrice Demoniere1, Baptiste Courty1, Rebecca Codiat1, Remi Neviere1,2, Jocelyn Inamo1,2.   

Abstract

Background: Impaired aerobic capacity in cardiac amyloidosis patients may be related to limited inotropic myocardial reserve and heart rate (HR) response limiting cardiac output rise. This study sought to investigate whether chronotropic incompetence (CI) and blunted HR recovery would be prevalent in patients with mutant transthyretin (ATTRv) cardiomyopathy.Methods and results: Eighteen ATTRv (Val122Ile) patients (72 ± 8-year) and 15 age-matched controls (73 ± 3-year) were prospectively enrolled. Patients' medical records, pulmonary function and cardiopulmonary exercise testing, including non-invasive cardiac hemodynamics and chronotropic response were studied. Compared with age-matched controls, maximal workload (91 ± 8 vs. 65 ± 20 watts) and peak VO2 (19.5 ± 3.0 vs. 14.4 ± 4.1 mL.kg-1.min-1) were lower in ATTRv patients. Despite reaching similar age-predicted maximal HR, ATTRv patients displayed smaller changes in stroke volume (SV) index relative to change in VO2 (49 ± 26 vs. 67 ± 18%). Adequate chronotropic-metabolic index was prevalent in ATTRv patients. HR recovery, as percent decrease in peak HR at 1 and 3-min, was blunded ATTv patients.Conclusions: In Val122Ile ATTRv patients, chronotropic response was appropriate relative to exercise intensity with only few patients displaying CI. HR response to exercise was further characterised by blunted HR recovery in ATTRv patients suggesting lower parasympathetic activity and greater sympathetic stimulation compared with controls.

Entities:  

Keywords:  Afro-Caribbean; Cardiac contractile reserve; aerobic capacity; chronotropic incompetence; mutant transthyretin carrier

Mesh:

Substances:

Year:  2020        PMID: 32024385     DOI: 10.1080/13506129.2020.1722098

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  4 in total

1.  Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review.

Authors:  Pranav Chandrashekar; Laith Alhuneafat; Meghan Mannello; Lana Al-Rashdan; Morris M Kim; Jason Dungu; Kevin Alexander; Ahmad Masri
Journal:  Circ Genom Precis Med       Date:  2021-08-31

2.  Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean Patients.

Authors:  Rishika Banydeen; Aissatou Signate; Tuan-Huy Tran; Astrid Monfort; Remi Neviere; Jocelyn Inamo
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

3.  Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients.

Authors:  Mael Padelli; Papa Gueye; Diane Guilloux; Rishika Banydeen; Valentine Campana; Andre Cabie; Remi Neviere
Journal:  Biomark Med       Date:  2022-01-27       Impact factor: 2.851

Review 4.  Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis.

Authors:  Rishika Banydeen; Astrid Monfort; Jocelyn Inamo; Remi Neviere
Journal:  Front Cardiovasc Med       Date:  2022-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.